corona vaccine News

Novavax COVID vaccine 90% effective in phase 3 trial

June 14, 2021 No Comments
Mary Van Beusekom | News Writer | CIDRAP News
Jun 14, 2021

The vaccine showed 100% protection against severe illness and 93% against variants of concern.

Mary Van Beusekom | News Writer | CIDRAP News

Jun 14, 2021
The vaccine showed 100% protection against severe illness and 93% against variants of concern.Read More

Leave a Reply

Your email address will not be published.